EN DE
Watch Beijing Airdoc Technology Co Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Beijing Airdoc Technology Co Ltd (2251) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Beijing Airdoc Technology Co Ltd stock HK$8.37, price HK$8.71, that is 3.9% below the price, quality 58 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare HK · Home China · ISIN CNE100004QQ9

BA Beijing Airdoc Technology Co Ltd logo Thin data Nov 10, 2026

Beijing Airdoc Technology Co Ltd

2251 · HK

Solid company, but the stock is already about fairly priced and falling price: meets 1 of 3 rules.

Get notified free when this changes
Fair value HK$8.37 · Fairly valued 
Quality 58/100 
Expensive Growth (revenue 5y +29.4 %/yr in CNY) 
Revenue last quarter 20% below a year ago. 
Falling price (downtrend) 
Loss-making · -46.0% net margin (TTM) 
Negative free cash flow 
Trails peers (3/9) 
Narrow moat 17/100
Thin data 
Estimate
Watch Beijing Airdoc Technology Co Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$68.00 HK$7.90 Fair Value HK$8.37 Nov 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range HK$7.90 – HK$68.00 · fair‑value band HK$6.28 – HK$10.46 · the HK$8.71 price screens above the HK$8.37 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Beijing Airdoc Technology Co in your weekly email

Every Wednesday you see whether Beijing Airdoc Technology Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Beijing Airdoc Technology Co., Ltd. provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally.

Show moreShow less

It offers AI-FUNDUSCAMERA-P, a portable, automated, and self-service fundus camera that enables retinal image acquisition; AI-FUNDUSCAMERA-U, a portable fundus camera for the popularization of eye health services; and AI-FUNDUSCAMERA-H, a multimodal health scanner integrating biosensors.

The company also provides AI-FUNDUSCAMERA-M, a portable intelligent image capture terminal; Airdoc-AIFUNDUS products for auxiliary diagnostic services to tertiary hospitals, primary healthcare institutions, and health checkup centers; and Airdoc vision rehabilitation instrument, a medical device to prevent axial myopia and aids in the auxiliary treatment of myopia.

In addition, it offers Airdoc Neuro-AI, a non-contact measurement product for stress resilience, and physiological and psychological stress; risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease, and anemia.

The company was formerly known as Beijing Tulip Partner Technology Co., Ltd. and changed its name to Beijing Airdoc Technology Co., Ltd. in December 2020. Beijing Airdoc Technology Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, the People's Republic of China.

Stock analysis

Beijing Airdoc Technology Co Ltd (2251) currently trades at HK$8.71, while our estimate is HK$8.37, so the stock looks roughly fairly valued today (gap 4.1%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: HK$6.28 (bear) to HK$10.46 (bull), the price of HK$8.71 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Beijing Airdoc Technology Co Ltd reported revenue of 173M CNY in FY2025 versus 115M CNY in FY2021, a compound +10.7%/yr. Reported net income was −25.0M CNY in FY2025.

Key figures

Market cap HK$880M (≈ $112M) Micro · P/S ratio 5.74 · Net margin −14.4% · Return on equity −6.0% · Return on assets (EBIT) −9.9% (5-year average) · Operating margin −44.0% · Revenue (TTM) 157M CNY · Revenue growth (YoY) −19.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 17 out of 100 (medium confidence).

What moves the price

The share trades about 35% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −4%, 2251 screens cheaper than that median.

Fair Value

Bear HK$6.28 Fair Value HK$8.37 Bull HK$10.46
Price HK$8.71 · Downside -3.9%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 58/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 8
How much profit the company makes from its sales and capital
Quality Growth 83
Are margins and returns getting better?
Cashflow 7
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 44
How calm the share price moves, does not count
Price momentum 21
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 8
Distance to the 52-week high, does not count
New shares 92
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+10.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+29.4%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+33.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−108.9% (2020) → −21.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch 2251, get fair value alerts →

Compare Beijing Airdoc Technology Co Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 142 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside −3.9% · Above median
Profitability
Return on assets −1.9% · Below median
Net margin (12 months) −46.0% · Bottom 25%
Operating margin (12 months) −44.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −19.6% · Bottom 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 0.61× · Cheapest 25%
P/S (12 months) 4.77× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)28 · sector 16
FUTURE (revenue growth)0 · sector 43
PAST (return on equity)0 · sector 3
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 44

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Veeva Systems Inc VEEV $301.53 $332.66 +10% vs 2251
Doximity, Inc DOCS $33.34 $36.67 +10% vs 2251
HealthEquity, Inc HQY $103.46 $113.36 +10% vs 2251
Waystar Holding WAY $27.99 $29.10 +4% vs 2251
Tempus AI, Inc TEM $71.60 $52.58 −27% vs 2251
HeartFlow, Inc HTFL $48.46 $30.56 −37% vs 2251
Hinge Health, Inc HNGE $115.39 $51.25 −56% vs 2251
Pro Medicus Limited PME A$201.66 A$85.12 −58% vs 2251
BrightSpring Health Services, Inc BTSG $71.21 $25.72 −64% vs 2251
XtalPi Holdings 2228 HK$5.87 HK$1.53 −74% vs 2251

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Beijing Airdoc Technology Co Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Beijing Airdoc Technology Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/2251

Frequently asked questions

Is Beijing Airdoc Technology Co Ltd (2251) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is HK$8.37 versus a price of HK$8.71, about 4% lower (fairly valued).
What is the fair value of 2251?
Our estimate for Beijing Airdoc Technology Co Ltd is HK$8.37 (as of Nov 10, 2026), built from audited fundamentals. The current price: HK$8.71.
What is the quality score of 2251?
Beijing Airdoc Technology Co Ltd has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Beijing Airdoc Technology Co Ltd (2251)?
Our calculated price target is the estimate of HK$8.37 (as of Nov 10, 2026). Cautious scenario HK$6.28, optimistic scenario HK$10.46. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Beijing Airdoc Technology Co Ltd stock forecast for 2026?
Our estimate puts fair value at HK$8.37, about 4% lower versus a price of HK$8.71 (fairly valued). Cautious scenario HK$6.28, optimistic scenario HK$10.46. The calculation is refreshed regularly with new filings.
What is the revenue of Beijing Airdoc Technology Co Ltd (2251)?
Beijing Airdoc Technology Co Ltd reported trailing-twelve-month revenue of about 157M CNY (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Beijing Airdoc Technology Co Ltd (2251)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Beijing Airdoc Technology Co Ltd it is HK$8.37 per share (as of Nov 10, 2026), against a price of HK$8.71.
Is Beijing Airdoc Technology Co Ltd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 2251 trades above its calculated fair value: price HK$8.71, fair value HK$8.37, a gap of about −4% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 2251?
No. The price is what the market pays today (HK$8.71); the fair value is what the company's own numbers justify (HK$8.37). For Beijing Airdoc Technology Co Ltd the two are HK$0.3400 per share apart. That gap is exactly why we show both numbers side by side.
How much is Beijing Airdoc Technology Co Ltd worth?
The market values Beijing Airdoc Technology Co Ltd at about HK$880M (market capitalisation, as of Nov 10, 2026). Per share that is HK$8.71; our models calculate a fair value of HK$8.37 per share.
What do the bullish and bearish scenarios say about 2251?
Our models span a range for Beijing Airdoc Technology Co Ltd: cautious scenario HK$6.28, base HK$8.37, optimistic HK$10.46 per share (as of Nov 10, 2026, price HK$8.71). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Beijing Airdoc Technology Co Ltd (2251)?
Balance-sheet figures for Beijing Airdoc Technology Co Ltd (as of Nov 10, 2026): return on equity −6.0%. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 2251 from its 52-week high?
Beijing Airdoc Technology Co Ltd trades at HK$8.71, about 35% below its 52-week high of HK$13.31 and 10% above the low of HK$7.90 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$8.37 is for.
Which stocks are comparable to Beijing Airdoc Technology Co Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Beijing Airdoc Technology Co Ltd stock attractive at the current price?
The data as of Nov 10, 2026: price HK$8.71, calculated fair value HK$8.37 (−4%), Quality Score 58/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Beijing Airdoc Technology Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Beijing Airdoc Technology Co Ltd (2251)?
The closing price on Nov 13, 2026 was HK$8.71. Our estimate is HK$8.37, about 4% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Beijing Airdoc Technology Co Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Beijing Airdoc Technology Co Ltd

How large is the market capitalisation of Beijing Airdoc Technology Co Ltd (2251)?
The market capitalisation of Beijing Airdoc Technology Co Ltd is HK$880M (≈ $112M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Beijing Airdoc Technology Co Ltd (2251)?
The price-to-sales ratio of Beijing Airdoc Technology Co Ltd is 5.74 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Beijing Airdoc Technology Co Ltd (2251)?
The net margin of Beijing Airdoc Technology Co Ltd is −14.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Beijing Airdoc Technology Co Ltd (2251)?
The return on equity (ROE) of Beijing Airdoc Technology Co Ltd is −6.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Beijing Airdoc Technology Co Ltd (2251)?
On an EBIT basis the return on assets of Beijing Airdoc Technology Co Ltd is −9.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Beijing Airdoc Technology Co Ltd (2251)?
The operating margin of Beijing Airdoc Technology Co Ltd is −44.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Beijing Airdoc Technology Co Ltd (2251)?
Revenue at Beijing Airdoc Technology Co Ltd is down 19.6% versus a year earlier (3y avg +15.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Beijing Airdoc Technology Co Ltd (2251) generate?
The free cash flow of Beijing Airdoc Technology Co Ltd is −21.1M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Beijing Airdoc Technology Co Ltd (2251) hold?
Beijing Airdoc Technology Co Ltd holds more cash than debt, 554M CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Beijing Airdoc Technology Co Ltd in the live analysis

One click puts Beijing Airdoc Technology Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.